Autologous marrow rescue in the treatment of leukemia is limited by the presence of occult viable leukemic cells in the marrow inoculum. The differential sensitivity of neoplastic versus normal hemopoietic cells supports the concept that ex vivo incubation of autologous marrow suspensions with selected cytotoxic agents may eliminate leukemic cells yet spare normal hemopoietic """"""""stem' cells. The proposed research will evaluate pharmacologic treatment of normal marrow and leukemic cell suspensions in a model of acute myelogenous leukemia (AML) in the Lewis-Brown Norway hybrid (LBN) rat. Four different agents will be studied: 4-hydroperoxycyclophos-phamide (4HC), bleomycin (BLEO), VP- 16, and m-AMSA. First, normal LBN marrow or AML cells will be incubated with increasing concentrations of each test drug. The treated normal marrow cells will be injected into lethally- irradiated syngeneic rats to assess drug effects on normal hemopoietic stem cells and hematologic reconstitution. Drug- treated AMl cells will be injected into unprepared LBN rats, and times to death from leukemia or leukemia-free survival, indicative of magnitude of elimination of AML cells by the drug treatment, will be determined. These dose-response curves will provide a range of drug concentrations with which mixtures of normal marrow and AML cells (to approximate a """"""""remission"""""""" marrow) will be incubated and injected into lethally-irradiated syngeneic rats to observe hematologic reconstitution, time to development of leukemia, and /or leukemia-free survival. Second, examination of sequential incubation of normal marrow. AML cells, and mixtures thereof with two of the above drugs will determine whehter combined sequential treatment with sub- curative doses of either durg alone may eradicate all clonogenic tumor yet not be toxic to normal rat marrow stem cells. In addition, complementary studies of the effects of incubation with these antineoplastic agents (singly and in combination) on the sensitivity of committed marrow-derived hemopoietic progenitor cells (granulocyte-macrophage colony-forming cells; GM-CFC) and a recently-described subline of LBN AML (the IPC-81 subline) will be conducted by in vitro clonogenic assays. These preclinical studies, which will develop principles for chemotherapeutic """"""""purging"""""""" of leukemic cells from syngeneic marrow, are germane to the development of therapeutic strategies in autologous marrow transplantation for human lymphohemopoietic malignancies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA040282-02
Application #
3180046
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1987-01-01
Project End
1989-12-31
Budget Start
1988-01-01
Budget End
1988-12-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Adamkiewicz, T V; Mehta, P S; Boyer, M W et al. (2004) Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Transplant 34:405-11
Mogul, M J; Forte, K J; Holland, H K et al. (1997) Steroid-refractory cutaneous graft-versus-host disease after transplantation of haploidentical parental CD34+ cells in children with Down's syndrome and recurrent acute leukemia. J Pediatr Hematol Oncol 19:142-4
Turner, C W; Yeager, A M; Waller, E K et al. (1996) Engraftment potential of different sources of human hematopoietic progenitor cells in BNX Mice. Blood 87:3237-44
Zhou, M; Gu, L; James, C D et al. (1995) Homozygous deletions of the CDKN2 (MTS1/p16ink4) gene in cell lines established from children with acute lymphoblastic leukemia. Leukemia 9:1159-61
Quigley, P M; Yeager, A M; Loughlin, G M (1994) The effects of bone marrow transplantation on pulmonary function in children. Pediatr Pulmonol 18:361-7
Yeager, A M (1993) Recent developments in experimental bone marrow transplantation. Curr Opin Oncol 5:282-9
Yeager, A M; Vogelsang, G B; Jones, R J et al. (1993) Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia. Leuk Lymphoma 11:215-20
Graham, M L; Yeager, A M; Leventhal, B G et al. (1992) Treatment of recurrent and refractory pediatric solid tumors with high-dose busulfan and cyclophosphamide followed by autologous bone marrow rescue. J Clin Oncol 10:1857-64
Yeager, A M; Shinn, C; Farmer, E R et al. (1992) Growth retardation and depigmentation of hair after high-dose busulfan and congenic hematopoietic cell transplantation in mice. Bone Marrow Transplant 9:199-204
Yeager, A M; Vogelsang, G B; Jones, R J et al. (1992) Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia. Blood 79:3031-5

Showing the most recent 10 out of 26 publications